Annual Operating Expenses
$65.99 M
-$13.14 M-16.61%
December 31, 2024
Summary
- As of March 13, 2025, XLO annual total operating expenses is $65.99 million, with the most recent change of -$13.14 million (-16.61%) on December 31, 2024.
- During the last 3 years, XLO annual operating expenses has fallen by -$9.05 million (-12.07%).
- XLO annual operating expenses is now -25.98% below its all-time high of $89.15 million, reached on December 31, 2022.
Performance
XLO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$15.35 M
-$1.71 M-10.04%
December 31, 2024
Summary
- As of March 13, 2025, XLO quarterly total operating expenses is $15.35 million, with the most recent change of -$1.71 million (-10.04%) on December 31, 2024.
- Over the past year, XLO quarterly operating expenses has dropped by -$2.78 million (-15.32%).
- XLO quarterly operating expenses is now -37.47% below its all-time high of $24.55 million, reached on June 30, 2022.
Performance
XLO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
XLO Operating Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -16.6% | -15.3% |
3 y3 years | -12.1% | -15.3% |
5 y5 years | +246.8% | -15.3% |
XLO Operating Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -26.0% | at low | -37.5% | at low |
5 y | 5-year | -26.0% | +246.8% | -37.5% | +5.0% |
alltime | all time | -26.0% | +246.8% | -37.5% | +5.0% |
Xilio Therapeutics Operating Expenses History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $65.99 M(-16.6%) | $15.35 M(-10.0%) |
Sep 2024 | - | $17.07 M(+0.2%) |
Jun 2024 | - | $17.03 M(+3.0%) |
Mar 2024 | - | $16.54 M(-8.8%) |
Dec 2023 | $79.13 M(-11.2%) | $18.13 M(+4.4%) |
Sep 2023 | - | $17.36 M(-13.7%) |
Jun 2023 | - | $20.12 M(-14.5%) |
Mar 2023 | - | $23.53 M(+1.5%) |
Dec 2022 | $89.15 M | $23.17 M(+14.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $20.21 M(-17.7%) |
Jun 2022 | - | $24.55 M(+15.7%) |
Mar 2022 | - | $21.22 M(+8.5%) |
Dec 2021 | $75.04 M(+37.5%) | $19.56 M(+22.5%) |
Sep 2021 | - | $15.96 M(-30.6%) |
Jun 2021 | - | $23.01 M(+39.3%) |
Mar 2021 | - | $16.52 M(-19.8%) |
Dec 2020 | $54.56 M(+186.8%) | $20.59 M(+40.8%) |
Sep 2020 | - | $14.62 M |
Dec 2019 | $19.03 M | - |
FAQ
- What is Xilio Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Xilio Therapeutics?
- What is Xilio Therapeutics annual operating expenses year-on-year change?
- What is Xilio Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly operating expenses year-on-year change?
What is Xilio Therapeutics annual total operating expenses?
The current annual operating expenses of XLO is $65.99 M
What is the all time high annual operating expenses for Xilio Therapeutics?
Xilio Therapeutics all-time high annual total operating expenses is $89.15 M
What is Xilio Therapeutics annual operating expenses year-on-year change?
Over the past year, XLO annual total operating expenses has changed by -$13.14 M (-16.61%)
What is Xilio Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of XLO is $15.35 M
What is the all time high quarterly operating expenses for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly total operating expenses is $24.55 M
What is Xilio Therapeutics quarterly operating expenses year-on-year change?
Over the past year, XLO quarterly total operating expenses has changed by -$2.78 M (-15.32%)